Regulatory
Progress Toward an Ethical Mindset
Everyone agrees that industry must move from rules- to values-based decision-making to ensure compliance ...
Talking About Your Pipeline
Ahead of commercialization, companies developing drugs and medical devices communicate about their pipeline products ...
Optimize Content Quality Globally
With anticipated launches of novel therapies and increasing sales for currently marketed prescription products, ...
Patient Experience Data and R&D
As the U.S. Food and Drug Administration (FDA) works to issue more guidance for ...
Technology Optimized Content
With the sheer volume and complexity of promotional materials today, it’s not surprising that ...
PFDD: A Game Changer?
The 21st Century Cures Act (Cures Act), which was passed by Congress, includes mandates ...
Pitfalls of Generic Drug Marketing
While many advertising agencies, companies, healthcare professionals, and consumers alike may not realize it, ...
That “Can Do” Attitude
Companies that are committed to patient-centered healthcare must incorporate the patient’s voice in all ...
Exhibit Displays: Beware the FDA
Companies attending large medical meetings to showcase innovative and marketed drug products alike should ...
The Trouble with Sampling in the State of Ohio
Have you ever heard about Ohio’s Terminal Distributor of Dangerous Drugs (TDDD) licenses? Before ...
Can Cross-Functional Leaders Competently Embrace Digital Innovation?
Is your company focused on accelerating digital transformation to become more patient-centric? That’s a ...
The FDA, Clinical Decision Support Tools, and the Medical Device Industry
As patients, caregivers, and healthcare professionals rely more on digital healthcare tools and the ...
Technology, Uncertainty, and the Life Sciences at a Tipping Point
Perhaps more than any concept in the life sciences industry, change is the single-most ...
